Stewart Abbot
Chief Tech/Sci/R&D Officer at TURNSTONE BIOLOGICS CORP.
Net worth: - $ as of 30/04/2024
Profile
Stewart Abbot is currently the Chief Scientific & Operating Officer at Adicet Therapeutics, Inc. and the Chief Scientific Officer at Turnstone Biologics Corp.
Previously, he held positions as the Senior Director-Research at Celgene Cellular Therapeutics, the Vice President-Translational Research at Fate Therapeutics, Inc., the SVP, Chief Operating & Scientific Officer at resTORbio, Inc., and the SVP, Chief Operating & Scientific Officer at Adicet Bio, Inc. Dr. Abbot obtained a doctorate degree from the University of London, an undergraduate degree from The University of Edinburgh, and a graduate degree from the University of Strathclyde.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/10/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Stewart Abbot active positions
| Companies | Position | Start |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Chief Operating Officer | 01/06/2018 |
Former positions of Stewart Abbot
| Companies | Position | End |
|---|---|---|
| ADICET BIO, INC. | Chief Operating Officer | 11/06/2021 |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 26/06/2018 |
| ADICET BIO, INC. | Chief Operating Officer | - |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Corporate Officer/Principal | - |
Training of Stewart Abbot
| The University of Edinburgh | Undergraduate Degree |
| University of London | Doctorate Degree |
| University of Strathclyde | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| ADICET BIO, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Private companies | 3 |
|---|---|
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Stewart Abbot
